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Abstract
Background: Research has indicated that general practitioners (GPs) have good clinical judgment in regards to
diagnosing and managing herpes zoster (HZ) within clinical practice in a country with limited resources for primary
care and general practice. The objective of the current study was to assess the burden of HZ and post herpetic
neuralgia (PHN) within rural general practices in Crete, Greece.
Methods: The current study took place within a rural setting in Crete, Greece during the period of November 2007
to November 2009 within the catchment area in which the Cretan Rural Practice-based Research Network is
operating. In total 19 GP’s from 14 health care units in rural Crete were invited to participate, covering a total
turnover patient population of approximately 25, 000 subjects. For the purpose of this study an electronic record
database was constructed and used as the main tool for monitoring HZ and PHN incidence. Stress related data
was also collected with the use of the Short Anxiety Screening Test (SAST).
Results: The crude incidence rate of HZ was 1.4/1000 patients/year throughout the entire network of health
centers and satellite practices, while among satellite practices alone it was calculated at 1.3/1000 patients/year.
Additionally, the standardised incidence density within satellite practices was calculated at 1.6/1000 patients/year.
In regards to the stress associated with HZ and PHN, the latter were found to have lower levels of anxiety, as
assessed through the SAST score (17.4 ± 3.9 vs. 21.1 ± 5.7; p = 0.029).
Conclusions: The implementation of an electronic surveillance system was feasible so as to measure the burden of
HZ and PHN within the rural general practice setting in Crete.
Background
Herpes zoster (HZ) is a common disease; its incidence
among the general population is estimated to be
between 3-4 persons per 1000 person-years, with pre-
vious research indicating that the incidence is higher
among the elderly, while is significantly lower among
those of younger age, notably before the age of 50 [1-3].
HZ itself is due to the localized reactivation of the vari-
cella-zoster virus within the ganglia where the virus has
remained dormant, usually from childhood. This reacti-
vation is accompanied commonly by a vesicular rash in
the same dermatomal distribution of the ganglion,
which is frequently in adjunct with pain. This pain may
linger after the disappearance of the rash itself, in the
form of HZ’s most common complication, post herpetic
neuralgia (PHN) [4]. PHN, is defined as the pain in the
involved dermatome that is still present after one month
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the patients quality of life and health costs as it may last
for several months to years [5-7] Social, psychological,
and environmental factors can influence a patient’s per-
ception of pain and their ability to cope with pain and
discomfort, and these factors should be taken into
account when optimal care is the aim [8]. It has further
been noted that the systematic evaluation of HZ related
adverse effects on health-related quality of life is still
needed due to its high incidence in the population of
the elderly [5].
It has been estimated that the incidence of HZ will
increase worldwide in the coming decades because of
the aging of the population, and possibly as a conse-
quence of childhood varicella vaccination [9,10]. Based
on recent EUROSTAT predictions for Greece this aging
of the population will translate into an increase in the
percentage over 65 from 18.6% to 31.7% [11].
Despite this negative prediction, Greece is a European
country in which no morbidity data for chronic or acute
diseases are routinely collected within Primary Health
Care. This serves as a barrier of the effective monitoring
of diseases in the community as well as towards the eva-
luation of the distribution of disease in relation to time,
place, geography and individual characteristics. This lack
of monitoring systems impedes the measurement of
effectiveness of both preventive and treatment efforts as
well as the assessment of health care needs.
With all of those in mind, within a country with cur-
rent financial restrictions and where primary health care
is not well developed, we designed and undertook this
study to measure the burden of HZ and PHN within
primary health care settings with the initial aim to test
the feasibility of a pilot surveillance system within the
current Greek primary health care setting. It has been
noted that few studies have evaluated the patient burden
and treatment of PHN in primary care, the usual locus
of chronic pain management [12].
Among the study’s main objectives were to measure
the incidence of HZ in geographically defined primary
care areas in rural Crete and to examine the demo-
graphic, clinical and psychosocial correlates of HZ in a
sample of patients who visited their local PHC services.
It was hypothesized that HZ patients within primary
care settings have a certain and distinguishable sociode-
mographic, pattern of utilization, disease profile and
anxiety status that could facilitate their timely identifica-
tion and effective treatment. To achieve the above, a
database to monitor HZ and PHN within rural primary
care in Greece was created and this paper reports the
HZ and PHN incidence, the utilization of primary care
services as well as the anxiety level in rural primary care
in Crete, while it also discusses its implications on both
health care research and health policy in this country.
Methods
Setting
The current study took place within a rural setting in
Crete, Greece between November 2007 to November
2009. General Practitioners (GPs) affiliated within the
Rural Practice-based Research Network of Crete, Greece,
a research initiative of the Clinic of Social and Family
Medicine of the University of Crete, were invited to par-
ticipate. In total 19 GPs were involved from 3 health
centers and 11 satellite practices with a total patient
turn over population of approximately 25, 000 subjects.
The participating GPs were informed during special
training days on how to handle the patients with HZ or
PHN that would visit their practice so as to offer them
inclusion or not within the study. All participating
patients provided written inform consent, while the
study protocol was reviewed and approved by the Ethics
Committee of the University Hospital of Heraklion,
Crete, Greece (Protocol number: 10984-16/10/2007).
Electronic database
An online electronic record database was constructed to
monitor the burden of HZ and PHN, as routinely used
within other primary care settings [13]. Through this
online platform that was applied for the first time within
primary care in Crete, participating physicians were able
to include new cases of HZ or PHN, and provide the
clinical, demographical and psychosocial information
requested by study protocol. This electronic database,
was password protected and through which enlisted
members could enter the data accordingly. The system
allowed each participating GP to view both their own,
and their peers performance in the study (recruitment
rate). The central research team, who had the role of
the database administrator, was only allowed access to
sensitive and personal data. The registry website is view-
able at http://fammed.med.uoc.gr/herpes.
Questionnaires
Two questionnaires were used to collect the necessary
background information. The first aimed to collect the
necessary demographic, descriptive and clinical aspects of
the patients with either HZ or PHN. The clinical section
covered aspects of the rash (duration, location), the pain
(duration, severity) and other co-morbidities. Information
was also collected in regards to the diagnosis and treat-
ment of HZ and PHN. HZ was physician diagnosed, while
PHN was physician assessed and defined as the presence
of pain 30 days after the rash appeared. So as to assess the
extent of pain endured due to the HZ rash or to PHN, the
patients were requested to quantify their pain and discom-
fort on a 7-point Likert scale ranging from 1 (no pain) to 7
(severe pain). The second questionnaire that was used was
the Short Anxiety Screening Test (SAST), which has been
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context of a primary care setting in Crete, Greece [14].
The questionnaire measured the level of anxiety that is
associated with HZ and PHN. It fulfills the criteria defined
by the Diagnostic and Statistical Manual of Mental Disor-
ders, fourth edition (DSM-IV) and consists of 10 items
rated on a 4 point response scale. The cumulative score
can range within 10-40, with a score of 24 regarded as the
cut-off point for the diagnosis of anxiety. Further informa-
tion on the validation and applications of this question-
naire is available in Grammatikopoulos et al study [14].
Measurement of the burden of herpes zoster
During the calculation of the incidence of HZ in the
population both HZ cases and PHN cases were regarded
as episodes of the recent Herpes virus reactivation, and
thus were combined in the subsequent estimation. The
crude annual incidence rate of HZ was calculated based
on the number of cases per 1000 patients/year and was
calculated separately for health centers and for the parti-
cipating remote practices. This separation was per-
formed as GPs in satellite practices serve a well defined
p o p u l a t i o n ,a si sn o tt h ec a s ea m o n gG P ss e r v i n gi n
health centers. These crude incidence rates were calcu-
lated as follows: (number of cases × 1000)/total patient
population per year. Adjusted incidence density rates
were calculated taking into account the number of days
that the GP was in practice during that specific year as
follows: (crude incidence rate × 365)/number of days in
practice. The latter was assessed only for satellite prac-
tices with one operating physician per day.
Statistical analysis
All p-values were based on two-sided tests and a signifi-
cance level lower than 0.05 was defined. Continuous
variables are presented as mean ± standard deviation,
while qualitative variables are depicted with the use of
frequencies. Student t tests and chi-squared (c
2)t e s t s
were used for detecting differences between sub groups
in regards to their clinical characteristics whereas inten-
sity of pain and anxiety were analyzed as continuous
variables. The statistical analysis was performed with the
statistical package SPSS 17.0. (Statistical Package for
Social Sciences, SPSS, Inc, Illinois, USA)
Results
Participants
Seventy three cases of HZ and PHN were registered.
Most of the participants with HZ and/or PHN were
female (56.3%, n = 36). The majority were married
(56.3%, n = 36) and of lower educational status (76.6%,
n = 49). The mean age of the participants was 67 ± 22.3
years. Detailed information on the participants’ sociode-
mographic characteristics are presented in Table 1.
Health care services’ utilization
Among the study participants, 96.9% (n = 62) first visited
the GP, while the other 3.2% (n = 2) reported seeking
advice from the pharmacist or another source of care. The
majority of the patients (62.5%, n = 40) first visited their
regional primary care facilities of the public health care
system, while only 6.3% (n = 4) and 7.8% (n = 8) visited a
private physician or a secondary hospital first respectively.
Burden of disease
Within the two year duration of the project 73 cases of
HZ or PHN were noted, 58 of which were in the acute
phase of HZ (79.4%) and 15 with PHN (20.6%) at the
time of case enrollment. However, consent was obtained
from 64 patients (55 with acute HZ and 9 with PHN),
for which personal and descriptive data were obtained.
Furthermore, the burden of disease was found to differ
by the time of year; through which more cases were
noted during winter (32%) and spring (32%) in compari-
son to summer (21%) and autumn (15%).
The crude incidence rate of HZ was 1.4/1000 patients/
year throughout the entire network (health centers and
satellite practices), while among satellite practices alone
it was calculated at 1.3/1000 patients/year. Additionally,
the adjusted incidence density was calculated at 1.6/1000
patients/year, having taken into account the number of
days that the practices operated. The complete number
of cases of HZ and PHN seen by the GPs as well as the
crude and adjusted incidence is depicted in Table 2.
Signs of HZ and PHN
Among patients with HZ, 69.1% (38/55) reported noti-
c i n gt h ep a i nb e f o r et h ed e v e l o p m e n to ft h eH Zr a s h .
The mean duration between the development of pain
and the HZ attributed rash was 5.2 days (range: 0-15
Table 1 Patients’ sociodemographic characteristics
(n = 64 with consent)
n%
Gender
Men 28 43.8
Women 36 56.3
Age* 67 22.3
Marital status
Married 36 56.3
Single 6 9.4
Divorced 3 4.7
Widow 19 29.7
Educational level
Elementary 49 76.6
Secondary 12 18.8
Tertiary 3 4.7
* Mean, standard deviation
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between the development of the rash and subsequently
seeking medical advice was 3.3 days (range: 0-12 days).
A significant percentage of the patients noted that their
rash was located on either their abdomen (29.1% n =
16), their chest (27.3%, n = 15), or in their lumbar area
(12.7%, n = 7). The patient’s skull and throat were loca-
tions noted in smaller percentages, at 7.3% (n = 4) and
9.1% (n = 5) respectively, while 49.1% (n = 27) of the
patients were found to have a rash which covered other
or overlapping anatomical areas of the body.
Among the characteristics attributed to the pain by
the patients, 60% (n = 33) of patients with HZ reported
the pain to cause a burning sensation, and 38.2% (n =
21) reported that it was continuous throughout the day.
On the other hand, among the patients diagnosed with
PHN, only 33.3% (n = 3) reported it as a burning sensa-
tion while 55.6% (n = 5) reported the pain to be contin-
uous and 11.1% (n = 1) reported it as a painful itching
sensation.
For patients with HZ, and as assessed at the time of
arrival at the GP’s practice and on the 0-7 Likert scale,
25.5% (n = 14) rated it as a 5/7, 23.6% (n = 13) as a 6/7
and 20.0% (n = 11) as a 4/7 on the Likert scale. Among
those with PHN, 4 out of the 9 patients rated the pain
with a 4/7 rating, 2 out of 9 reported a 7/7 rating, and 1
patient reported their pain to be 6/7 on the Likert scale.
Of the 64 patients with HZ and PHN, co-morbidities,
such as hypertension (49.2%, n = 31), hyperlipidaimia
(38.1%, n = 24), diabetes mellitus (19.0%, n = 12), cor-
onary heart disease (17.5%, n = 11), chronic obstructive
pulmonary disease (6.5%, n = 4), and malignant neo-
plasms (1.6%, n = 1) were noted.
Anxiety assessment
Among the patients that were registered in the study,
35.9% (n = 23) were identified as positive in the SAST
test (with a score ≥ 24), while an additional 5 patients
manifested a marginal result (with a score of 22-23).
When comparing the patients with HZ to the patients
with PHN, the latter were found to have lower levels of
anxiety, with a mean score of 17.4 ± 3.9 vs. 21.1 ± 5.7
indicating that those within the acute phase of HZ had
higher SAST scores and this noted difference was statis-
tically significant (p = 0.029). Moreover the self reported
level of pain and the SAST score per individual were
not correlated (rho = 0.204, p > 0.05). An additional
analysis was performed so as to assess whether the
patients level of anxiety played a role in seeking medical
help from the regional GP or elsewhere, to which no
differences were noted between the two groups (p >
0.05) (Mean score 20.9 ± 5.6 vs. 20.2 ± 5.6 for those
that visited first their PHC physician or another physi-
cian respectively).
Discussion
Main findings
Most of the episodes of varicella virus reactivation in
rural Crete were documented in the acute phase. The
crude incidence rate calculated throughout the entire
primary care network was similar to the lower end of
incidence of HZ studies in community settings, which
Table 2 Crude and adjusted HZ incidence within participating general practices in rural Crete, Greece
Primary Care Unit Acute phase HZ PHN Total HZ episodes Crude Incidence
1 Adjusted Incidence
2
Satellite Practices
SP 1 10 3 13 7.2 7.2
SP 2 1 4 5 4.5 4.6
SP 3 16 2 18 12.9 14.6
SP 4 3 0 3 0.3 0.3
SP 5 9 0 9 5 5.1
SP 6 4 1 5 0.4 0.4
SP 7 5 0 5 1.25 1.3
SP 8 1 0 1 0.6 1.4
SP 9 0 0 0 0 0
SP 10 0 0 0 0 0
SP 11 0 0 1 0 0
Health Centers
HC 1 1 2 3 1.5 3
HC 2 6 2 8 1.8 1.9
HC 3 2 1 3 1.5 2.6
Total 58 15 73 1.4 1.6
1: based on the number of cases per 1000 patients/year
2: based on the number of cases per 1000 patients/year taking into account the number of days that the GP was in practice during that specific year
Lionis et al. BMC Family Practice 2011, 12:136
http://www.biomedcentral.com/1471-2296/12/136
Page 4 of 7have reported annual incidence rates ranging from 1.3
to 4.8 per 1, 000 persons [15-18] without taking age
into account, while among elder patients an annual inci-
dence of 3.6 to 14.2 per 1000 has been reported [15].
Notably, this is observed despite the fact that access to
the Greek national health care system is not based on a
primary care gate-keeping regiment and therefore
patients may seek healthcare elsewhere. Additionally,
there are no existing primary care oriented data in
Greece regarding the incidence of HZ and PHN, and
the absence of an electronic encounter recording system
within PHC could be partially responsible for the lack of
such information [19]. This study provides some evi-
dence on the feasibility of implementing a monitoring
system within regional health care facilities, through the
mobilization of GPs and with the provision of limited
funding. With this reasoning, the region of Crete could
be representative at a national level for both the estima-
tion of the burden of HZ and PHN but also for the
applicability of an electronic surveillance system for dis-
ease monitoring within PHC in Greece. To our knowl-
edge, it is the first effort in reporting the frequency of
HZ in primary care in Greece, an effort well established
in UK and the Netherlands years ago [20].
HZ patient profile
This study revealed that the common HZ profile in
rural Crete were lower educated, elder females with par-
ticipants in the acute phase of HZ reactivation found to
have higher levels of anxiety when compared to partici-
pants with PHN. Indeed, previous research has indicated
that those living alone, and showing increased anxiety or
depression are at high risk of PHN persisting [21,22].
Assuming the effects of these psychosocial variables are
causal, it has been hypothesized that PHN would be
reduced by interventions that either encourage patients’
participation in daily activities to the greatest extent
p o s s i b l eo rr e d u c ep a t i e n t s ’ emotional distress [23].
Within the context of our study, and as assessed with
the use of the SAST questionnaire, participants during
the acute phase of HZ were found to have a higher
anxiety score, a fact which we most likely attribute to
their personal response to the intense combination of
discomfort and pain through the development of the
rash/pain.
Implications
Research on the cost effectiveness of herpes zoster vac-
cination among the elderly in the US has indicated that
the provision of 1 million vaccines would lead to a US$
82-103 million reduction in health care costs due to the
diagnosis, treatment and avoided complications [24]. In
the US, the direct medical cost burden of HZ in the US
is high, exceeding $US1000 per HZ patient. This direct
medical cost may be nearly twice as high in immuno-
compromised patients and four times as high in the
subset of HZ cases with PHN [25]. There are studies,
which report a lower incidence as well as less severity of
HZ among individuals vaccinated with varicella vaccine
[26,27]. Investigation and detailed monitoring of the
effect of vaccination against varicella into the overall HZ
incidence, represent special research targets and could
foster research within primary care [19].
In addition to the above, a significant percentage of
the study population had other co-morbidities including
diabetes, renal failure, malignancies and coronary heart
disease a fact that would further reduce patient quality
of life and health care expenditure. As indicated by
other researchers, the healthcare costs associated with
PHN are substantially greater than those associated with
herpes zoster pain that is resolved within 30 days
[28,29]. It is this above information regarding the costs
associated with prolonged pain that would be especially
relevant in determining the cost-effectiveness of emer-
ging prevention strategies [30]. The role of the GP in
the above strategy is significant, as research has indi-
cated that family physicians have good clinical judgment
in regards to diagnosing herpes zoster. A clinical study
by Opstelten et al., corroborated the above fact within a
primary care setting, and found that the clinical diagno-
sis could be confirmed serologically in 91% of patients
with signs and symptoms of herpes zoster [31].
Strengths and weaknesses
This observational study has several limitations. Com-
bining cases of HZ and cases of PHN may overestimate
the incidence of HZ. The small number of patients may
limit the ability to detect potentially significant associa-
t i o n sa n dt h i sf a c t o rm a yh a v eb e e ni n t r o d u c e db ya
lacking or deficient electronic patient records system
that impedes the disease’s monitoring. A selection bias
may be introduced since the study included patients
who were seeking medical care at the participating pri-
mary care centers. It is possible that some individuals
developing very mild cases of HZ may not have sought
medical care. Recall bias may have also affected the
study results since some information was collected by
self-report. Moreover we must state that the health care
system in Greece, is not based on a gate-keeping system
and therefore it is possible that some patients with HZ
or PHN may have visited GP’s or other physicians that
s e r v ee i t h e rp u b l i co rp r i v a t es e c t o ro u t s i d eo ft h ea r e a
under their responsibility. It can be lead to an underesti-
mation of both the incidence of HZ and the burden of
this disease. Another point of concern is the generalisa-
bility of the results to the entire population of Greece,
mostly in regards to the participants with PHN. It is
also possible that the patients with less severe pain did
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first to provide information on epidemiological aspects
of HZ in Greece as also provide an insight into the use
of the primary care services based on an electronic data-
base. Finally, due to its cross-sectional design, no causal-
ity can be attributed from these findings in regards to
the association between patient’s increased anxiety or
depression and the occurrence of PHN, a fact that not
even prospective studies have indicated to date [20].
However, it was clear that the main contribution of this
study was the measurement of the burden of the HZ
that the selected primary care services in rural Crete are
invite to manage.
Conclusions
The study provides evidence on the feasibility of primary
care surveillance systems to monitor acute or chronic dis-
orders within Greece a fact previously noted in northern
European settings [32]. Such initiatives seem very promis-
ing for HZ morbidity reporting in a country with limited
resources that has a limited use of electronic databases.
T h ec u r r e n ts t u d yp r o v i d e sa l s os o m ee v i d e n c ef o rt h e
timely identification of HZ patients within primary care
settings. Patients with a higher risk of developing HZ that
are identified, might benefit from future preventive strate-
gies. Moreover, the knowledge of a HZ profile could assist
physicians in better understanding the disease characteris-
tics and could further facilitate timely detection within the
busy schedule of primary care physicians.
List of Abbreviations
HZ: Herpes Zoster; PHN: Post Herpetic Neuralgia; GP: General Practitioner;
SAST: Short Anxiety Screening Test; PCP: primary care practice.
Author details
1Department of Social Medicine, Clinic of Social and Family Medicine,
Faculty of Medicine, University of Crete, PO Box 2208, Postal Code 71003,
Greece.
2Center for Global Tobacco Control, Department of Society, Human
Development and Health, Harvard School of Public Health 677 Huntington
Avenue, Boston, MA 02115, USA.
3Primary Care Practice of Pirgos, Heraklion
Postal Code 70010, Crete, Greece.
4Health Center of Spili, Rethymnon Postal
Code 74053, Crete, Greece.
5Primary Care Practice of Mallia, Heraklion Postal
Code 70007, Crete, Greece.
6Health Center of Agia Varvara, Heraklion Postal
Code 70003, Crete, Greece.
7Primary Care Practice of Skinia, Heraklion Postal
Code 70300, Crete, Greece.
82nd Department of Psychiatry, Aristotle
University of Thessaloniki, Psychiatric Hospital of Thessaloniki, Postal Code
54124, Greece.
9Primary Care Practice of Vraxasi, Heraklion Postal Code
72400, Crete, Greece.
10Health Center of Anogeia, Rethymnon Postal Code
74051, Crete, Greece.
11Primary Care Practice of Episkopi, Heraklion Postal
Code 70008, Crete, Greece.
12Primary Care Practice of Zoniana, Rethymnon
Postal Code 74051, Crete, Greece.
13Primary Care Practice of Hersonisos,
Heraklion Postal Code 70014, Crete, Greece.
14Primary Care Practice of Peza,
Heraklion Postal Code 70100, Crete, Greece.
15Primary Care Practice of
Ebaros, Heraklion Postal Code 70015, Crete, Greece.
16Primary Care Practice
of Asites, Heraklion Postal Code 70013, Crete, Greece.
17Primary Care Practice
of Moxos, Heraklion Postal Code 70005, Crete, Greece.
Authors’ contributions
CL had the main role in study conception and design. CV, EKS contributed
to study protocol preparation, while author CL, EKS, CV and MP contributed
to manuscript preparation and data interpretation. All the remaining authors
contributed to data collection and management. All authors have read and
approved the final manuscript.
Competing interests
The Clinic of Social and Family Medicine at the School of Medicine,
University of Crete, under the scientific coordination of CL, has received a
grant by the Vaccine Business Unit (Sanofi Pasteur MSD) of VIANEX S.A. The
established standards were followed with the University of Crete’s Special
Account for Research managing the funding. The organization funding this
study had no role in the design and conduct of the study; the collection,
analysis, and interpretation of the data; or the preparation, review or
approval of the manuscript.
Received: 26 July 2011 Accepted: 6 December 2011
Published: 6 December 2011
References
1. Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR:
Herpes zoster burden of illness and health care resource utilisation in
the Australian population aged 50 years and older. Vaccine 2009,
27:520-9.
2. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA: The incidence of
herpes zoster in a United States administrative database. J Gen Intern
Med 2005, 20:748-753.
3. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van
Essen GA: Herpes zoster and postherpetic neuralgia: incidence and risk
indicators using a general practice research database. Fam Pract 2002,
19:471-475.
4. Tyring SK: Management of herpes zoster and postherpetic neuralgia. J
Am Acad Dermatol 2007, 57(Suppl 6):S136-42.
5. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH: Acute pain in
herpes zoster and its impact on health-related quality of life. Clin Infect
Dis 2004, 39:342-348.
6. Kost RG, Straus SE: Postherpetic neuralgia-pathogenesis, treatment and
prevention. N Eng J Med 1996, 335:32-42.
7. McElhaney JE: Herpes zoster: a common disease that can have a
devastating impact on patients’ quality of life. Expert Rev Vaccines 2010,
9:27-30.
8. Johnson RW: Consequences and management of pain in herpes zoster. J
Infect Dis 2002, 186:S83-S90.
9. Brisson M, Edmunds WJ, Gay NJ: Varicella vaccination: impact of vaccine
efficacy on the epidemiology of VZV. J Med Virol 2003, 70:S31-S37.
10. Schuette MC, Hethcote HW: Modeling the effects of varicella vaccination
programs on the incidence of chickenpox and shingles. Bull Math Biol
1999, 61:1031-1064.
11. Giannakouris K: Population and Social conditions: Ageing characterises
the demographic perspectives of the European Societies.[http://epp.
eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-SF-08-072/EN/KS-SF-08-072-EN.
PDF], last accessed 20 November 2010.
12. Markman JD, Dukes E, Siffert J, Griesing T: Patient flow in neuropathic pain
management: understanding existing patterns of care [Abstract]. Eur J
Neurol 2004, 11(Suppl 2):135-6.
13. Truyers C, Lesaffre E, Bartholomeeusen S, Aertgeerts B, Snacken R,
Brochier B, Yane F, Buntinx F: Computerized general practice based
networks yield comparable performance with sentinel data in
monitoring epidemiological time-course of influenza-like illness and
acute respiratory illness. BMC Fam Pract 2010, 11:24.
14. Grammatikopoulos IA, Sinoff G, Alegakis A, Kounalakis D, Antonopoulou M,
Lionis C: The Short Anxiety Screening Test in Greek: translation and
validation. Ann Gen Psychiatry 2010.
15. Thomas SL, Hall AJ: What does epidemiology tell us about risk factors for
herpes zoster? Lancet Infect Dis 2004, 4:26-33.
16. Hope-Simpson RE: The nature of herpes zoster: A long-term study and a
new hypothesis. Proc R Soc Med 1965, 58:9-20.
17. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO: Population-
based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982,
61:310-6.
18. Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Lepiege A, El
Hasnaoui A, de Lebareyre C: Characteristics of patients with herpes zoster
on presentation to practitioners in France. Clin Infect Dis 2001, 33:62-9.
Lionis et al. BMC Family Practice 2011, 12:136
http://www.biomedcentral.com/1471-2296/12/136
Page 6 of 719. Lionis C, Symvoulakis EK, Vardavas CI: Implementing family practice
research in countries with limited resources: a stepwise model
experienced in Crete, Greece. Fam Pract 2010, 27:48-54.
20. Fleming DM, Bartelds A, Chapman RS, Cross KW: The consistency of
shingles and its significance for health monitoring. Eur J Epidemiol 2004,
19:1113-8.
21. Dworkin R, Hartstein G, Rosner H, Walther RR, Sweeney E, Brand L: A high-
risk method for studying psychosocial antecedents of chronic pain: the
prospective investigation of herpes zoster. J Abnorm Psychol 1992,
101:200-5.
22. Engberg IB, Grondahl G, Thibom K: Patients’ experiences of herpes zoster
and postherpetic neuralgia. J Adv Nurs 1995, 21:427-433.
23. Katz J, McDermott MP, Cooper EM, Walther RR, Sweeney EW, Dworkin RH:
Psychosocial risk factors for postherpetic neuralgia: a prospective study
of patients with herpes zoster. J Pain 2005, 6:782-90.
24. Pellissier JM, Brisson M, Levin MJ: Evaluation of the cost-effectiveness in
the United States of a vaccine to prevent herpes zoster and
postherpetic neuralgia in older adults. Vaccine 2007, 25:8326-37.
25. White RR, Lenhart G, Singhal PK, Insinga RP, Itzler RF, Pellissier JM,
Segraves AW: Incremental 1-year medical resource utilization and costs
for patients with herpes zoster from a set of US health plans.
Pharmacoeconomics 2009, 27:781-92.
26. Plotkin SA, Starr SE, Connor K, Morton D: Zoster in normal children after
varicella vaccine. J Infect Dis 1989, 159:1000-1.
27. Gershon A, Silverstein S: Live attenuated vaccine varicella vaccine for
prevention of herpes zoster. Biologicals 1997, 25:227-30.
28. Dworkin RH, White R, O’Connor AB, Baser O, Hawkins K: Healthcare costs
of acute and chronic pain associated with a diagnosis of herpes zoster. J
Am Geriatr Soc 2007, 55:1168-75.
29. Dworkin RH, White R, O’Connor AB, Hawkins K: Health care expenditure
burden of persisting herpes zoster pain. Pain Med 2008, 9:348-53.
30. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD,
Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD,
Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC,
Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF,
Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, et al:
Shingles Prevention Study Group. A vaccine to prevent herpes zoster
and postherpetic neuralgia in older adults. N Engl J Med 2005,
352:2271-84.
31. Opstelten W, van Loon AM, Schuller M, van Wijck AJ, van Essen GA,
Moons KG, Verheij TJ: Clinical diagnosis of herpes zoster in family
practice. Ann Fam Med 2007, 5:305-9.
32. Opstelten W, Zuithoff NP, van Essen GA, van Loon AM, van Wijck AJ,
Kalkman CJ, Verheij TJ, Moons KG: Predicting postherpetic neuralgia in
elderly primary care patients with herpes zoster: prospective prognostic
study. Pain 2007, 132(Suppl 1):S52-9.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2296/12/136/prepub
doi:10.1186/1471-2296-12-136
Cite this article as: Lionis et al.: Measuring the burden of herpes zoster
and post herpetic neuralgia within primary care in rural Crete, Greece.
BMC Family Practice 2011 12:136.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lionis et al. BMC Family Practice 2011, 12:136
http://www.biomedcentral.com/1471-2296/12/136
Page 7 of 7